The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary edema, noncardiogenic (NCPE)
Publications
A case report on acute pulmonary edema induced by adverse drug event immediately after cesarean section.
International journal of surgery case reports 2025 Jan 29;128;110991 — 2025 Jan 29 — 110991
Oxytocin-Induced Acute Pulmonary Edema: A Case Report and Literature Review.
Cureus 2021 May 16;13;e15067 — 2021 May 16 — e15067
Fatal pulmonary oedema following oxytocin administration in a pregnant woman with acute myocardial infarction.
Cardiovascular toxicology 2011 Mar;11;74-7 — 2011 Mar — 74-7
Acute pulmonary oedema following oxytocin administration: a life threatening complication.
Journal of the Indian Medical Association 2006 May;104;261-2 — 2006 May — 261-2
Pulmonary edema during cesarean section related to the use of oxytocic drugs.
Acta anaesthesiologica Belgica 1984 Jun;35;155-64 — 1984 Jun — 155-64
The cardiovascular effects of oxytocic drugs.
British journal of anaesthesia 1972 Aug;44;826-34 — 1972 Aug — 826-34
Pulmonary edema possibly developing secondary to the intravenous administration of oxytocin.
Veterinary and human toxicology 1991 Dec;33;587-8 — 1991 Dec — 587-8